Le Bonheur, UT Health Sciences participating in pediatric antibody trial
MEMPHIS, Tenn. — Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center in Memphis are enrolling pediatric volunteers in a clinical trial for a COVID-19 antibody treatment, according to a news release.
The release says volunteers should be children and adolescents up to 18-years-old. The trial will look at how these volunteers respond to Regeneron’s investigational antibody treatment REGEN-COV, the release says.
The treatment has been approved for emergency use, according to the release.
Recruitment of patients quickly after their first positive COVID-19 test is critical, the release syas.
For more information on the clinical trial and how to enroll, click here.